Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria

Mostrar otras versiones (1)

BACKGROUND: The World Health Organization (WHO) recommends artemisinin‐based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria. Concerns about artemisinin resistance have led to global initiatives to develop new partner drugs to protect artemisinin derivatives in ACT....

Descripción completa

Detalles Bibliográficos
Autores principales: Pryce, Joseph, Taylor, Melissa, Fox, Tilly, Hine, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209011/
https://www.ncbi.nlm.nih.gov/pubmed/35726133
http://dx.doi.org/10.1002/14651858.CD006404.pub4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209011/
https://www.ncbi.nlm.nih.gov/pubmed/35726133
http://dx.doi.org/10.1002/14651858.CD006404.pub4

Ejemplares similares